Novo Integrated Sciences, Inc. Common Stock
NVOS
NVOS was delisted on the 5th of November, 2024.
16 hedge funds and large institutions have $814K invested in Novo Integrated Sciences, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 0 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
7% more funds holding
Funds holding: 15 → 16 (+1)
1.79% more ownership
Funds ownership: 3.94% → 5.73% (+1.8%)
56% less capital invested
Capital invested by funds: $1.87M → $814K (-$1.06M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$237K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$233K |
| 3 |
VF
Virtu Financial
New York
|
+$175K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$24.6K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$22.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$10.1K |
| 2 |
LFAS
Level Four Advisory Services
Dallas,
Texas
|
-$7.1K |
| 3 |
Millennium Management
New York
|
-$4.83K |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$4K |
NVOS Hedge Fund Activity: Q4 2023 in Review
16 of the 6,871 institutional investors tracked by Wall St. Rank reported a position in Novo Integrated Sciences, Inc. Common Stock (NVOS) for Q4 2023, worth a combined $814K — down 56% from $1.87M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new NVOS positions and 4 closed out — a net gain of 1 holder — while 10 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $237K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $10.1K sold.
- 16 institutional investors held Novo Integrated Sciences, Inc. Common Stock (NVOS) as of Q4 2023, up from 15 in Q3 2023.
- Funds reported $814K of Novo Integrated Sciences, Inc. Common Stock stock for Q4 2023, down 56% quarter-over-quarter.
- 5 funds opened new Novo Integrated Sciences, Inc. Common Stock positions in Q4 2023 and 4 closed out, a net change of +1 holder.
- The largest Novo Integrated Sciences, Inc. Common Stock buyer in Q4 2023 was Citadel Advisors, an estimated $237K added.
- The largest Novo Integrated Sciences, Inc. Common Stock seller in Q4 2023 was Two Sigma Securities, an estimated $10.1K sold.
Based on aggregated 13F filings for Q4 2023.